186 related articles for article (PubMed ID: 35301576)
1. Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
Löwenmark T; Li X; Löfgren-Burström A; Zingmark C; Ling A; Kellgren TG; Larsson P; Ljuslinder I; Wai SN; Edin S; Palmqvist R
Cancer Immunol Immunother; 2022 Oct; 71(10):2565-2575. PubMed ID: 35301576
[TBL] [Abstract][Full Text] [Related]
2. Tumour Colonisation of
Löwenmark T; Löfgren-Burström A; Zingmark C; Ljuslinder I; Dahlberg M; Edin S; Palmqvist R
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497419
[TBL] [Abstract][Full Text] [Related]
3. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
[TBL] [Abstract][Full Text] [Related]
4. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
6. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
7. Synergistic biofilm formation by Parvimonas micra and Fusobacterium nucleatum.
Horiuchi A; Kokubu E; Warita T; Ishihara K
Anaerobe; 2020 Apr; 62():102100. PubMed ID: 31521732
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
9. Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer.
Purcell RV; Visnovska M; Biggs PJ; Schmeier S; Frizelle FA
Sci Rep; 2017 Sep; 7(1):11590. PubMed ID: 28912574
[TBL] [Abstract][Full Text] [Related]
10. Strain specificity in fusobacterial co-aggregation with colorectal cancer-relevant species.
Robinson AV; Allen-Vercoe E
Anaerobe; 2023 Aug; 82():102758. PubMed ID: 37423597
[TBL] [Abstract][Full Text] [Related]
11. Impact of
Kim YJ; Kim BK; Park SJ; Kim JH
World J Gastroenterol; 2021 Aug; 27(29):4879-4889. PubMed ID: 34447232
[TBL] [Abstract][Full Text] [Related]
12. Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients.
Zhao L; Zhang X; Zhou Y; Fu K; Lau HC; Chun TW; Cheung AH; Coker OO; Wei H; Wu WK; Wong SH; Sung JJ; To KF; Yu J
Oncogene; 2022 Sep; 41(36):4200-4210. PubMed ID: 35882981
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
15.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers.
Chen Y; Lu Y; Ke Y; Li Y
Medicine (Baltimore); 2019 Sep; 98(39):e17221. PubMed ID: 31574832
[TBL] [Abstract][Full Text] [Related]
17. Detection of
Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
[TBL] [Abstract][Full Text] [Related]
18. Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma.
Conde-Pérez K; Buetas E; Aja-Macaya P; Martin-De Arribas E; Iglesias-Corrás I; Trigo-Tasende N; Nasser-Ali M; Estévez LS; Rumbo-Feal S; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LA; Bou G; Mira A; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1143-1173. PubMed ID: 37558206
[TBL] [Abstract][Full Text] [Related]
19. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
[TBL] [Abstract][Full Text] [Related]
20. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
